OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for HealthCare Global Enterprises's OCF Yield % or its related term are showing as below:
NSE:HCG'
s OCF Yield % Range Over the Past 10 Years
Min: 3.87 Med: 0 Max: 3.87
Current: 3.87
During the past 12 years, the highest OCF Yield % of HealthCare Global Enterprises was 3.87%. The lowest was 3.87%. And the median was %.
NSE:HCG's OCF Yield % is ranked worse than 56.87% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 5.48
vs NSE:HCG: 3.87
HealthCare Global Enterprises OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
HealthCare Global Enterprises OCF Yield % Related Terms
HealthCare Global Enterprises OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's OCF Yield % distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises (NSE:HCG) has a OCF Yield % of 3.87 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HealthCare Global Enterprises and its competitors. Over the past decade, HealthCare Global Enterprises' OCF Yield % has ranged from 3.87 to 3.87. According to the industry distribution chart, HealthCare Global Enterprises ranks #389 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 56.9%.
Is HealthCare Global Enterprises' OCF Yield % too high?
HealthCare Global Enterprises' current OCF Yield % is 3.87. Over the past 10 years, this metric has ranged from a low of 3.87 to a high of 3.87. The Healthcare Providers & Services industry median OCF Yield % is 5.48. HealthCare Global Enterprises' value of 3.87 is 29.4% below this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #389 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' OCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #389 out of 684 companies for OCF Yield %. This places HealthCare Global Enterprises in the lower half of its industry. The industry median OCF Yield % is 5.48. HealthCare Global Enterprises' value of 3.87 is 29.4% below this benchmark. Historically, HealthCare Global Enterprises' own OCF Yield % has ranged from 3.87 to 3.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.48, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current OCF Yield % of 3.87 is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current OCF Yield % is 3.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Fairly Valued. The stock's GF Value™ is ₹577.43, compared to a current price of ₹633.95 — trading 9.8% above its estimated fair value. The current OCF Yield % is 3.87 and 29.4% below the Healthcare Providers & Services industry median of 5.48. HealthCare Global Enterprises' overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current OCF Yield % is 3.87 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹633.95 is trading 9.8% above its estimated GF Value™ of ₹577.43.
GuruFocus considers HealthCare Global Enterprises to be Fairly Valued.
Key valuation signals for NSE:HCG:
OCF Yield %: 3.87
GF Value™: ₹577.43 vs. price of ₹633.95 (9.8% above fair value)
Industry Position: 29.4% below the Healthcare Providers & Services median (#389 of 684)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
79GF Score
Get the complete analysis for NSE:HCG
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
